This company listing is no longer active
Clinical Laserthermia Systems Crecimiento futuro
Future controles de criterios 2/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Clinical Laserthermia Systems.
Información clave
56.9%
Tasa de crecimiento de los beneficios
50.0%
Tasa de crecimiento del BPA
| Crecimiento de los beneficios de Medical Equipment | 27.0% |
| Tasa de crecimiento de los ingresos | 56.5% |
| Rentabilidad financiera futura | n/a |
| Cobertura de analistas | Low |
| Última actualización | 24 Feb 2023 |
Actualizaciones recientes sobre el crecimiento futuro
No hay actualizaciones
Recent updates
No hay actualizaciones
Previsiones de crecimiento de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Flujo de caja libre | Flujo de caja operativo | Núm. de analistas medio |
|---|---|---|---|---|---|
| 12/31/2025 | 115 | -2 | N/A | N/A | 1 |
| 12/31/2024 | 44 | -45 | -48 | -45 | 1 |
| 12/31/2023 | 17 | -70 | -70 | -67 | 1 |
| 3/31/2023 | 6 | -78 | -71 | -68 | N/A |
| 12/31/2022 | 6 | -71 | -69 | -68 | N/A |
| 9/30/2022 | 3 | -81 | -81 | -81 | N/A |
| 6/30/2022 | 2 | -63 | -66 | -66 | N/A |
| 3/31/2022 | 2 | -68 | -71 | -71 | N/A |
| 12/31/2021 | 2 | -64 | -67 | -66 | N/A |
| 9/30/2021 | 1 | -60 | -63 | -63 | N/A |
| 6/30/2021 | 2 | -57 | -55 | -55 | N/A |
| 3/31/2021 | 2 | -47 | -41 | -41 | N/A |
| 12/31/2020 | 1 | -58 | -56 | -55 | N/A |
| 9/30/2020 | 1 | -58 | -54 | -53 | N/A |
| 6/30/2020 | 2 | -57 | -54 | -54 | N/A |
| 3/31/2020 | 6 | -54 | -52 | -52 | N/A |
| 12/31/2019 | 6 | -43 | -39 | -39 | N/A |
| 9/30/2019 | 6 | -38 | -37 | -36 | N/A |
| 6/30/2019 | 5 | -37 | -35 | -34 | N/A |
| 3/31/2019 | 1 | -41 | -44 | -43 | N/A |
| 12/31/2018 | 8 | -33 | -41 | -39 | N/A |
| 9/30/2018 | 10 | -28 | -33 | -31 | N/A |
| 6/30/2018 | 11 | -24 | -33 | -31 | N/A |
| 3/31/2018 | 12 | -15 | -29 | -24 | N/A |
| 12/31/2017 | 8 | -21 | -29 | -24 | N/A |
| 9/30/2017 | 8 | -22 | -34 | -29 | N/A |
| 6/30/2017 | 8 | -26 | -28 | -24 | N/A |
| 3/31/2017 | 6 | -27 | -24 | -23 | N/A |
| 12/31/2016 | 4 | -27 | N/A | -20 | N/A |
| 9/30/2016 | 1 | -27 | N/A | -19 | N/A |
| 6/30/2016 | 0 | -23 | N/A | -22 | N/A |
| 3/31/2016 | 0 | -20 | N/A | -17 | N/A |
| 12/31/2015 | N/A | -17 | N/A | -19 | N/A |
| 9/30/2015 | 0 | -21 | N/A | -21 | N/A |
| 6/30/2015 | 0 | -20 | N/A | -20 | N/A |
| 3/31/2015 | 0 | -20 | N/A | -19 | N/A |
| 12/31/2014 | N/A | -18 | N/A | -16 | N/A |
| 9/30/2014 | 0 | -16 | N/A | -18 | N/A |
| 6/30/2014 | N/A | -16 | N/A | -18 | N/A |
| 3/31/2014 | N/A | -17 | N/A | -17 | N/A |
| 12/31/2013 | N/A | -18 | N/A | -18 | N/A |
| 9/30/2013 | 0 | -16 | N/A | -13 | N/A |
| 6/30/2013 | N/A | -15 | N/A | -12 | N/A |
| 3/31/2013 | 0 | -13 | N/A | -11 | N/A |
| 12/31/2012 | N/A | -13 | N/A | -12 | N/A |
| 9/30/2012 | 0 | -11 | N/A | -10 | N/A |
Previsiones de crecimiento futuro de los analistas
Ingresos vs. Tasa de ahorro: CLS UR B is forecast to remain unprofitable over the next 3 years.
Beneficios vs. Mercado: CLS UR B is forecast to remain unprofitable over the next 3 years.
Beneficios de alto crecimiento: CLS UR B is forecast to remain unprofitable over the next 3 years.
Ingresos vs. Mercado: CLS UR B's revenue (56.5% per year) is forecast to grow faster than the Swedish market (5.5% per year).
Ingresos de alto crecimiento: CLS UR B's revenue (56.5% per year) is forecast to grow faster than 20% per year.
Previsiones de crecimiento de los beneficios por acción
Rentabilidad financiera futura
ROE futura: Insufficient data to determine if CLS UR B's Return on Equity is forecast to be high in 3 years time